drugset / Trial / NCT01026909

Intraarticular Corticosteroid Therapy in Perthes Disease.

NCT01026909

Terminated 3 enrolled Seattle Children's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Legg-Calve-Perthes disease (LCP) represents the loss of blood flow to the head of the femur, resulting in significant hip pain and potential long term disability. This study represents a single center, randomized, prospective, controlled study comparing the treatment of LCP with an intraarticular corticosteroid (triamcinolone hexacetonide) injection with traditional nonoperative treatment.

Timeline

Start
2009-03
Primary completion
2013-10
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Hexacetonide Other / unclassified 20 mg Other